查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464059

2024 年全球細胞裂解與分級分離市場報告

Cell Lysis And Fractionation Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

細胞裂解和分離市場規模預計在未來幾年將強勁成長。 2028年，將以7.5%的複合年成長率成長至45.7億美元。預測期內的預期擴張是由於對個人化醫療的日益關注、政府對研究的資助增加、對高效研究技術的更大需求、基因組學和蛋白​​質組學的技術進步以及對慢性病和感染疾病病率上升的需求增加。預測期內預計的主要趨勢包括個性化醫療方法採用的持續成長、裂解和分餾過程中自動化和機器人技術的提高、臨床診斷和藥物開發以及細胞分析方面的廣泛應用，其中包括微流體和實驗室晶片的照護現場。​

隨著對個人化醫療的日益關注，細胞裂解和分離市場預計在未來幾年將顯著成長。個人化醫療是一種不斷發展的醫療方法，它利用個體的遺傳特徵來有效診斷和治療疾病。這意味著透過關注每個患者的獨特特徵，尤其是他們的基因組成來制定醫療決策和治療方案。細胞裂解和分級分離是精準醫學的基本組成部分，可以從患者樣本中分離和分析特定的亞細胞成分，例如蛋白質、細胞器和核酸。這種能力使科學家和醫療保健專業人員能夠闡明疾病的分子機制，並根據每個患者獨特的分子特徵開發個人化治療。特別是，個人化醫療聯盟(PMC) 預測，各種疾病類別的基因檢測產品和個人化藥物的可用性將顯著增加，並且個人化醫療將繼續塑造醫療保健格局，我們強調它們發揮著非常重要的作用。因此，人們越來越關注個人化醫療，這是推動細胞裂解和分離市場擴張的主要因素。

細胞裂解和分離市場的主要參與者正在積極實施先進的解決方案，以在不斷發展的市場競爭中獲得優勢。這種創新的一個例子是開發 CGT（細胞和基因治療）病毒載體裂解套件，旨在簡化病毒載體裂解過程並提高工作流程標準化和安全性。這些套件提供了一種簡化的腺結合病毒(AAV) 裂解方法，並有助於準確定量細胞裂解物中多種血清型的病毒滴度。例如，領先的樣品和檢測技術提供者 QIAGEN 於 2023 年 7 月推出了 CGT 病毒載體裂解試劑盒。這項創新解決方案補充了 QIAGEN 針對生物製藥產業的廣泛數位 PCR 產品組合，並強調了我們對不斷發展細胞裂解和分級分離技術以滿足市場不斷變化的需求的承諾。透過為病毒載體裂解提供強大且標準化的解決方案，QIAGEN 等公司在促進個人化醫療的廣泛採用並推動細胞裂解和分級分離市場的成長方面處於有利地位，我們準備好發揮重要作用。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球細胞裂解和分餾市場的驅動和限制因素
    • 市場驅動力
    • 市場限制因素
  • 全球細胞裂解和分級分離市場表現：規模和成長，2018-2023 年
  • 全球細胞裂解和分餾市場預測：規模和成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球細胞裂解和分餾市場：按類型、實際和預測分類，2018-2023、2023-2028、2033
  • 哺乳動物細胞
  • 微生物細胞
  • 全球細胞裂解和分餾市場：按應用、性能和預測，2018-2023、2023-2028、2033
  • 核酸精製與分離
  • 蛋白質精製與分離
  • 全球細胞裂解和分餾市場：按最終用戶、性能和預測，2018-2023、2023-2028、2033
  • 實驗室和實驗室
  • 生物製藥
  • 生技公司

第 7 章 區域/國家分析

  • 全球細胞裂解和分餾市場：按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球細胞裂解和分餾市場：按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 細胞裂解與分離市場：競爭格局
  • 細胞裂解與分離市場：公司簡介
    • Hoffmann-La Roche Ltd
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company

第31章 其他大型創新企業

  • Lonza Group AG
  • Illumina Inc.
  • Beckman Coulter Inc.
  • PerkinElmer Inc.
  • IDEX Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Eppendorf AG
  • Miltenyi Biotec BV & Co. KG
  • Promega Corporation
  • Takara Bio Inc.
  • Abcam plc
  • Cell Signaling Technology Inc.
  • BioVision Inc.
  • Diagenode LLC

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r16790

Cell lysis and fractionation are interconnected methods utilized in biological research to rupture cells and segregate their constituents for analysis. Cell lysis involves disintegrating a cell to discharge its contents, comprising proteins, nucleic acids, and additional biological elements. Conversely, fractionation entails segregating cellular components based on their size, shape, density, charge, or other attributes.

The primary types of cell lysis and fractionation involve mammalian cells and microbial cells. Mammalian cells are eukaryotic cells derived from mammals, commonly used in cell culture and the biomanufacturing of therapeutic proteins and viral vaccines. These cells find applications in various processes such as nucleic acid and protein purification, and are utilized by research laboratories, institutes, biopharmaceutical, and biotechnology companies.

The cell lysis and fractionation market research report is one of a series of new reports from The Business Research Company that provides cell lysis and fractionation market statistics, including cell lysis and fractionation industry global market size, regional shares, competitors with cell lysis and fractionation market share, detailed cell lysis and fractionation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell lysis and fractionation industry. This cell lysis and fractionation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell lysis and fractionation market size has grown strongly in recent years. It will grow from $3.14 billion in 2023 to $3.42 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The expansion during the historical period can be credited to the rise in investments in life science research, heightened emphasis on personalized medicine, widespread occurrence of diseases, technological progressions in cell lysis and fractionation techniques, and the increasing demand for biopharmaceuticals and biotechnology products.

The cell lysis and fractionation market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The expansion anticipated in the forecast period is driven by a heightened focus on personalized medicine, augmented government funding for research, substantial demand for efficient cell lysis and fractionation techniques, technological advancements in genomics and proteomics, and an escalating prevalence of chronic and infectious diseases. Significant trends expected in the forecast period encompass sustained growth in the adoption of personalized medicine methodologies, greater incorporation of automation and robotics in lysis and fractionation procedures, broadening applications in clinical diagnostics and drug development, advancements in microfluidics and lab-on-a-chip technologies for cell analysis, and an increased emphasis on point-of-care and decentralized testing solutions.

The increasing emphasis on personalized medicine is poised to drive significant growth within the cell lysis and fractionation markets in the coming years. Personalized medicine, an evolving medical approach, leverages an individual's genetic profile to diagnose and treat diseases effectively. It entails tailoring medical decisions and therapies to each patient's unique characteristics, particularly focusing on their genetic makeup. Cell lysis and fractionation serve as fundamental components of precision medicine, enabling the isolation and analysis of specific subcellular components from patient samples, including proteins, organelles, and nucleic acids. This capability empowers scientists and healthcare professionals to delve into the molecular mechanisms underlying diseases and develop personalized treatments based on each patient's distinct molecular traits. Notably, the Personalized Medicine Coalition (PMC) projects a significant rise in the availability of genetic testing products and personalized medicines across various disease categories, further underscoring the pivotal role of personalized medicine in shaping the landscape of healthcare. Consequently, the increasing emphasis on personalized medicine emerges as a primary driver propelling the expansion of the cell lysis and fractionation markets.

Key players within the cell lysis and fractionation markets are actively pursuing the introduction of advanced solutions to gain a competitive edge in the evolving landscape. One such innovation is exemplified by the development of CGT (cell and gene therapy) viral vector lysis kits, designed to streamline viral vector lysis processes and enhance workflow standardization and safety. These kits offer a simplified methodology for Adeno-associated virus (AAV) lysis, facilitating precise quantification of virus titers across multiple serotypes from cell lysates. For instance, QIAGEN, a leading provider of sample and assay technologies, launched the CGT Viral Vector Lysis Kit in July 2023, aimed at enabling precise and uniform virus titer quantification for various serotypes. Complementing QIAGEN's extensive digital PCR portfolio for the biopharmaceutical industry, this innovative solution underscores the company's commitment to advancing cell lysis and fractionation technologies to meet the evolving demands of the market. By providing robust and standardized solutions for viral vector lysis, companies such as QIAGEN are poised to play a pivotal role in facilitating the broader adoption of personalized medicine and driving growth within the cell lysis and fractionation markets.

In December 2022, MilliporeSigma, a pharmaceutical company based in the United States, finalized the acquisition of Erbi Biosystems Inc. for an undisclosed sum. Through this strategic move, MilliporeSigma aims to bolster its portfolio and expertise in the bioreactors and cell culture technologies sector. Erbi Biosystems is renowned as the developer of the Breez platform technology, a 2 ml micro-bioreactor platform known for its micro-scale, fully automated, and functionally closed system. Erbi Biosystems Inc., based in the United States, specializes in providing microfluidic solutions designed to facilitate efficient and controlled cell lysis and fractionation..

Major companies operating in the cell lysis and fractionation market report are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

North America was the largest region in the cell lysis and fractionation market in 2023. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell lysis and fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell lysis and fractionation market consists of revenues earned by entities by providing cellular contents extraction, cytoplasmic separation, and cell disruption. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell lysis and fractionation market also includes sales of cell lysis instruments, cell lysis reagents, and consumables. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Lysis And Fractionation Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell lysis and fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell lysis and fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell lysis and fractionation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Mammalian Cells; Microbial Cells
  • 2) By Application: Nucleic Acid Purification And Isolation; Protein Purification And Isolation
  • 3) By End-User: Research Laboratories And Institutes; Biopharmaceutical; Biotechnology Companies
  • Companies Mentioned: Hoffmann-La Roche Ltd; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Lysis And Fractionation Market Characteristics

3. Cell Lysis And Fractionation Market Trends And Strategies

4. Cell Lysis And Fractionation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell Lysis And Fractionation Market Size and Growth

  • 5.1. Global Cell Lysis And Fractionation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell Lysis And Fractionation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell Lysis And Fractionation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Lysis And Fractionation Market Segmentation

  • 6.1. Global Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Mammalian Cells
  • Microbial Cells
  • 6.2. Global Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nucleic Acid Purification And Isolation
  • Protein Purification And Isolation
  • 6.3. Global Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Laboratories And Institutes
  • Biopharmaceutical
  • Biotechnology Companies

7. Cell Lysis And Fractionation Market Regional And Country Analysis

  • 7.1. Global Cell Lysis And Fractionation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell Lysis And Fractionation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Lysis And Fractionation Market

  • 8.1. Asia-Pacific Cell Lysis And Fractionation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Lysis And Fractionation Market

  • 9.1. China Cell Lysis And Fractionation Market Overview
  • 9.2. China Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Lysis And Fractionation Market

  • 10.1. India Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Lysis And Fractionation Market

  • 11.1. Japan Cell Lysis And Fractionation Market Overview
  • 11.2. Japan Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Lysis And Fractionation Market

  • 12.1. Australia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Lysis And Fractionation Market

  • 13.1. Indonesia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Lysis And Fractionation Market

  • 14.1. South Korea Cell Lysis And Fractionation Market Overview
  • 14.2. South Korea Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Lysis And Fractionation Market

  • 15.1. Western Europe Cell Lysis And Fractionation Market Overview
  • 15.2. Western Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Lysis And Fractionation Market

  • 16.1. UK Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Lysis And Fractionation Market

  • 17.1. Germany Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Lysis And Fractionation Market

  • 18.1. France Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Lysis And Fractionation Market

  • 19.1. Italy Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Lysis And Fractionation Market

  • 20.1. Spain Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Lysis And Fractionation Market

  • 21.1. Eastern Europe Cell Lysis And Fractionation Market Overview
  • 21.2. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Lysis And Fractionation Market

  • 22.1. Russia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Lysis And Fractionation Market

  • 23.1. North America Cell Lysis And Fractionation Market Overview
  • 23.2. North America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Lysis And Fractionation Market

  • 24.1. USA Cell Lysis And Fractionation Market Overview
  • 24.2. USA Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Lysis And Fractionation Market

  • 25.1. Canada Cell Lysis And Fractionation Market Overview
  • 25.2. Canada Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Lysis And Fractionation Market

  • 26.1. South America Cell Lysis And Fractionation Market Overview
  • 26.2. South America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Lysis And Fractionation Market

  • 27.1. Brazil Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Lysis And Fractionation Market

  • 28.1. Middle East Cell Lysis And Fractionation Market Overview
  • 28.2. Middle East Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Lysis And Fractionation Market

  • 29.1. Africa Cell Lysis And Fractionation Market Overview
  • 29.2. Africa Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Lysis And Fractionation Market Competitive Landscape And Company Profiles

  • 30.1. Cell Lysis And Fractionation Market Competitive Landscape
  • 30.2. Cell Lysis And Fractionation Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton, Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell Lysis And Fractionation Market Other Major And Innovative Companies

  • 31.1. Lonza Group AG
  • 31.2. Illumina Inc.
  • 31.3. Beckman Coulter Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. IDEX Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. QIAGEN NV
  • 31.8. Eppendorf AG
  • 31.9. Miltenyi Biotec B.V. & Co. KG
  • 31.10. Promega Corporation
  • 31.11. Takara Bio Inc.
  • 31.12. Abcam plc
  • 31.13. Cell Signaling Technology Inc.
  • 31.14. BioVision Inc.
  • 31.15. Diagenode LLC

32. Global Cell Lysis And Fractionation Market Competitive Benchmarking

33. Global Cell Lysis And Fractionation Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Lysis And Fractionation Market

35. Cell Lysis And Fractionation Market Future Outlook and Potential Analysis

  • 35.1 Cell Lysis And Fractionation Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell Lysis And Fractionation Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell Lysis And Fractionation Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer